# OnCo record rejuv-frontier-mesenchymal-stromal-cells (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-frontier-mesenchymal-stromal-cells/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-frontier-mesenchymal-stromal-cells" ;
  schema:name "Mesenchymal stromal cells for tissue damage"@en ;
  schema:description "There is one licensed mesenchymal cell product in oncology and it is for one narrow use: children whose graft-versus-host disease has not responded to steroids. Everything else sold as a mesenchymal or stromal cell infusion for repair or rejuvenation is unlicensed and untested, and it is worth knowing the difference because the clinics rely on it being blurred."@en ;
  schema:url <https://onco.cc/technologies/rejuv-frontier-mesenchymal-stromal-cells/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mesenchymal_stem_cell> ;
  schema:citation <https://doi.org/10.1182/blood.2025028553>, <https://doi.org/10.1001/jama.2025.6179>, <https://www.gov.uk/guidance/advanced-therapy-medicinal-products-regulation-and-licensing-in-uk> ;
  onco:status "approved" ;
  onco:tag "rejuvenation", "survivorship", "evidence:moderate", "cell-therapy" ;
  onco:related <https://onco.cc/technologies/rejuv-frontier-stem-cell-tourism/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/> ;
  onco:terms <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .